In our case–control study, we examined MMP-2 and MMP-9 genotypic profiles in 798 Taiwanese subjects, including 218 UTUC cases and 580 non-UTUC controls (as shown in Table 1). This evidence concerns the gene MMP9 and renal pelvis/ureter urothelial carcinoma.